Authors:
Camicioli, R
Lea, E
Nutt, JG
Sexton, G
Oken, BS
Citation: R. Camicioli et al., Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study, CLIN NEUROP, 24(4), 2001, pp. 208-213
Authors:
Heikkinen, H
Nutt, JG
LeWitt, PA
Koller, WC
Gordin, A
Citation: H. Heikkinen et al., The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease, CLIN NEUROP, 24(3), 2001, pp. 150-157
Authors:
Rascol, O
Nutt, JG
Blin, O
Goetz, CG
Trugman, JM
Soubrouillard, C
Carter, JH
Currie, LJ
Fabre, N
Thalamas, C
Giardina, WJ
Wright, S
Citation: O. Rascol et al., Induction by dopamine D-1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease, ARCH NEUROL, 58(2), 2001, pp. 249-254
Authors:
Nutt, JG
Lea, ES
Van Houten, L
Schuff, RA
Sexton, GJ
Citation: Jg. Nutt et al., Determinants of tapping speed in normal control subjects and subjects withParkinson's disease: Differing effects of brief and continued practice, MOVEMENT D, 15(5), 2000, pp. 843-849
Citation: Jg. Nutt, Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients, NEUROLOGY, 55, 2000, pp. S33-S37